- Report
- October 2025
- 160 Pages
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- June 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- December 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Report
- March 2025
- 150 Pages
Global
From €3358EUR$3,850USD£2,927GBP
€4230EUR$4,850USD£3,687GBP
- Directory
- February 2026
Global
From €3445EUR$3,950USD£3,003GBP
- Report
- September 2025
- 135 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- June 2025
- 106 Pages
Global
From €3009EUR$3,450USD£2,623GBP
- Report
- May 2025
- 120 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- February 2025
- 135 Pages
Global
From €4230EUR$4,850USD£3,687GBP
- Report
- October 2025
- 100 Pages
United States
From €5190EUR$5,950USD£4,523GBP
- Report
- April 2025
- 122 Pages
Europe
From €3489EUR$4,000USD£3,041GBP
- Report
- January 2026
- 80 Pages
Europe
From €4143EUR$4,750USD£3,611GBP
- Report
- July 2025
- 250 Pages
North America
From €3375EUR$3,869USD£2,941GBP
- Report
- November 2025
- 70 Pages
Middle East, Africa
From €3009EUR$3,450USD£2,623GBP
- Report
- November 2025
- 97 Pages
Asia Pacific
From €3445EUR$3,950USD£3,003GBP

Personalized Medicine in Oncology is a field of medicine that uses genomic information to tailor treatments to individual patients. This approach is based on the idea that each patient's cancer is unique and requires a personalized approach to treatment. Genomics is used to identify the genetic mutations that are driving the cancer, and then treatments are tailored to target those mutations. This approach has the potential to improve outcomes and reduce side effects, as treatments are more targeted and tailored to the individual patient.
Companies in the Personalized Medicine in Oncology market include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, and PerkinElmer. Show Less Read more